Jim Simons acquired 35.3k FibroGen shares worth $320k. That's 0.00% of their equity portfolio (2583rd largest holding). The investor owns 2.30% of the outstanding FibroGen stock. The first FibroGen trade was made in Q3 2016. Since then Jim Simons bought shares eighteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $411k, resulting in a loss of 22%.